Neonatal hypoxia and drugs of ingredients of metformin hydrochloride - a phase IV clinical study of FDA data
Neonatal hypoxia is reported only by a few people who take drugs with ingredients of metformin hydrochloride. This phase IV clinical study analyzes 450,855 people who have side effects while taking drugs with ingredients of metformin hydrochloride from the the FDA. Among them, 4 have Neonatal hypoxia. Find out below who they are, when they have Neonatal hypoxia and more.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Fortamet, Glucophage, Glucophage xr, Glumetza, Metformin, Metformin hydrochloride, Riomet, Riomet er.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
450,855 people reported to have side effects when taking drugs with ingredients of metformin hydrochloride.
Among them, 4 people (0.0%) have Neonatal hypoxia
What is Neonatal hypoxia?
Neonatal hypoxia (lack of oxygen in neonate) is found to be associated with 193 drugs and 91 conditions by eHealthMe.
Number of reports submitted per year:
Gender of people who have Neonatal hypoxia when taking drugs with ingredients of metformin hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Neonatal hypoxia when taking drugs with ingredients of metformin hydrochloride *:
- 0-1: 100 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Conditions people have *:
- High Blood Pressure: 2 people, 50.00%
- Conjunctivitis Viral (infection of conjunctiva by virus): 1 person, 25.00%
Other drugs people take *:
- Lescol: 2 people, 50.00%
- Actos: 2 people, 50.00%
- Lastacaft: 1 person, 25.00%
- Blopress: 1 person, 25.00%
Other side effects people have besides Neonatal hypoxia *:
- Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 2 people, 50.00%
- Hypoglycaemia Neonatal (deficiency of glucose in the bloodstream in neonatal): 2 people, 50.00%
- Blood Creatinine Increased: 2 people, 50.00%
- Blood Electrolytes Abnormal: 2 people, 50.00%
- Blood Phosphorus Abnormal: 2 people, 50.00%
- Blood Sodium Decreased: 2 people, 50.00%
- Blood Urea Increased: 2 people, 50.00%
- Chest X-Ray Abnormal: 2 people, 50.00%
- Cyanosis Neonatal (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails in newborn): 2 people, 50.00%
- Drug Exposure During Pregnancy: 2 people, 50.00%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
Drugs with ingredients of metformin hydrochloride, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cabometyx and Faecaloma - 5 seconds ago
- Omeprazole and Diaphragmatic Disorder - 6 seconds ago
- Flagyl and Acne - 7 seconds ago
- Zoladex and Lacrimation Increased - 15 seconds ago
- Glipizide and Necrosis - 16 seconds ago
- Asa and Prostatic Specific Antigen Increased - 24 seconds ago
- Ceftriaxone and Iron Deficiency Anaemia - 27 seconds ago
- Alphagan and Prostatic Specific Antigen Increased - 28 seconds ago
- Macular Degeneration and drugs of ingredients of alpha - lipoic acid - 34 seconds ago
- Isosorbide Mononitrate and Deafness Neurosensory - 39 seconds ago